Core Viewpoint - The first trial date in the Multi District Litigation against Pfizer Inc. has been set for December 2026, with over 2,100 women alleging that Pfizer did not adequately warn patients about known risks [1] Group 1: Legal Proceedings - A Case Management Conference was held where the Honorable M. Casey Rodgers announced the trial date [1] - The litigation involves more than 2,100 women pursuing claims against Pfizer [1] Group 2: Regulatory Context - The announcement of the trial date follows a recent label change approval by the US Food and Drug Administration (FDA) for Pfizer's product [1]